Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-30 | Mary Ann Gray, Ph.D. 56 Director |
| 2010-04-23 | Mary Ann Gray, Ph.D. has served as a director of our company since April 2005. ... The Board of Directors has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. ... The following table shows for the fiscal year ended December 31, 2009 certain information with respect to the compensation of all persons who served as directors of the Company during the year, other than Dr. Hacksell, who is a Named Executive Officer and received no additional compensation for his services as a director: ... Mary Ann Gray: Fees Earned or Paid in Cash includes $16,000 in Board of Directors and Audit Committee meetings fees and $15,000 of Dr. Gray’s $25,000 annual retainer paid in cash. Option Awards includes the fair value of 10,000 stock options and 13,888 stock options (from the forty percent conversion of a $25,000 annual retainer) granted on June 12, 2009 with an exercise price of $2.16. As of December 31, 2009, an aggregate of 83,023 stock options that had been granted to Dr. Gray were outstanding. |
| 2011-04-25 | Mary Ann Gray, Ph.D. 58 Director ... Director Compensation for Fiscal 2010 ... Mary Ann Gray(5) Fees Earned or Paid in Cash includes $15,500 in Board of Directors, Audit Committee and Compensation Committee meetings fees. Option Awards includes the fair value of 10,000 stock options and 57,692 stock options (from the conversion of a $25,000 annual retainer) each granted on June 11, 2010 with an exercise price of $1.30. As of December 31, 2010, an aggregate of 150,715 stock options that had been granted to Dr. Gray were outstanding. |
| 2012-04-18 | Mary Ann Gray ... Board of Directors, Audit Committee and Compensation Committee meetings fees plus an annual retainer of $25,000. Option Awards includes the fair value of 10,000 stock options granted on June 10, 2011 with an exercise price of $1.75. Total compensation was $53,988. |
| 2013-04-25 | Mary Ann Gray has served as a director since April 2005. She chairs the Audit Committee and is a member of the Compensation Committee and Nominating and Corporate Governance Committee. Director Compensation for Fiscal 2012 shows Mary Ann Gray earned $17,000 in cash and $69,134 in option awards, totaling $86,134. |
| 2014-04-23 | Mary Ann Gray, Ph.D. 61 Director |
| 2015-04-29 | Mary Ann Gray, Ph.D. has served as a director of our company since April 2005. ... The Board has an Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Mary Ann Gray Fees Earned or Paid in Cash includes Annual Retainer of $35,000, Additional Retainer for Audit Chair of $18,000, and Additional Retainer for Compensation Member (non-Chair) of $7,000. Option Awards includes the fair value of 12,500 stock options granted on June 6, 2014 with an exercise price of $21.99. Total compensation $265,215. |
| 2016-04-29 | Mary Ann Gray X * X The Audit Committee has determined that all members of the Audit Committee are independent. The Compensation Committee is composed of two directors and all members of the Compensation Committee are independent. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-21 | Dr. Gray received a B.S. from University of South Carolina, a Ph.D. in pharmacology from the University of Vermont, and completed her post-doctoral work at Northwestern University Medical School and at the Yale University School of Medicine. |
| 2022-08-31 | Mary Ann Gray, Ph.D. |
| 2022-08-31 | Mary Ann Gray, Ph.D. ... Cristina Csimma, PharmD, M.H.P., Mary Ann Gray, Ph.D. and Binxian Wei, each an existing director of Seneca, remained on the Board. |
| 2023-04-21 | Dr. Gray has a Ph.D. in Pharmacology from the University of Vermont where she focused on novel chemotherapeutic agents for the treatment of cancer. |
| 2024-02-06 | Mary Ann Gray, Ph.D.(8) Includes (i) 80 shares of common stock and (ii) 966 shares of common stock underlying stock options. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-26 | Mary Ann Gray, Ph.D. has served as a member of our Board since December 2010. She also serves as a member of our compensation committee and as a member of our nominating and corporate governance committee. ... The current members of the compensation committee are Claude Nicaise, M.D. (Chairman), Richard J. Barry and Mary Ann Gray, Ph.D. ... The current members of the nominating and corporate governance committee are Richard J. Barry (Chairman), Hans Wigzell, M.D., Ph.D. and Mary Ann Gray, Ph.D. ... The following table sets forth compensation information for our current and former non-employee directors that served on our Board in 2018. ... Mary Ann Gray, Ph.D. $356,243 cash, $375,134 stock awards, total $731,377. |
| 2020-04-21 | Mary Ann Gray, Ph.D. has served as a member of our Board since December 2018. She also serves as a member of our compensation committee, our audit committee and our nominating and corporate governance committee. |
| 2021-04-20 | Mary Ann Gray, Ph.D. has served as a member of our Board since December 2018. She also serves as a member of our compensation committee, our audit committee and our nominating and corporate governance committee. ... Our nominating and corporate governance committee believes that Dr. Gray’s extensive experience in the biotechnology and biopharmaceutical industry qualifies her for service as a member of our Board. |
| 2022-04-25 | Mary Ann Gray, Ph.D. has served as a member of our Board since June 2010. She also serves as a member of our audit committee and nominating and corporate governance committee. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22